Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Endocrinology

Diagnosis and Understanding Your Test Results

At a Glance

Hypopituitarism is diagnosed with carefully timed hormone tests, not one random blood test. Morning cortisol and other paired hormone results may be followed by stimulation testing, a pituitary MRI, and visual field testing when indicated.

Diagnosing hypopituitarism is a precise, multi-step process. Because your hormone levels naturally fluctuate throughout the day, doctors cannot rely on a single random blood test [1]. Instead, they use a combination of “basal” (resting) tests and “dynamic” (provocative) tests to see how your hormone axes perform [2].

Important Safety Warning Before Testing

Never stop taking prescribed hydrocortisone, inhaled steroids, or topical steroid creams before a blood test unless explicitly instructed to do so by your endocrinologist. Stopping glucocorticoids abruptly on your own can precipitate a life-threatening adrenal crisis. Always disclose every medication and supplement you take so your doctor can interpret your labs correctly.

The Basal Workup: The 8:00 AM Snapshot

The first step is a series of blood tests taken early in the morning, usually between 8:00 AM and 9:00 AM, when your hormone levels should be at their peak [1][3]. The timing requirement applies particularly to cortisol/ACTH, while other hormones have different interpretation considerations.

  • Adrenal Axis: Doctors measure morning cortisol. While cutoffs vary by laboratory, a very low level (often below 3 µg/dL) strongly suggests deficiency, while a high level (often above 15 µg/dL) usually means the axis is healthy [4]. Results in between are considered a “gray zone” and require further testing [5]. These numbers are assay-specific guideposts; your specialist must interpret them.
  • Thyroid Axis: Unlike primary hypothyroidism, where TSH is high, central hypothyroidism is marked by a low Free T4 level combined with a TSH that looks “normal,” low, or slightly elevated but biologically inappropriate [6].
  • Growth Hormone (GH) Axis: A random GH test is almost never useful because GH is released in short bursts [7]. Instead, doctors measure IGF-1 (Insulin-like Growth Factor-1), which is more stable [8]. However, a normal IGF-1 does not always rule out a deficiency, especially in adults [9].
  • Other Axes: Testing includes Prolactin, LH, and FSH, along with Testosterone (in men) or Estradiol (in women) [10].

Dynamic Stimulation Testing: The “Stress Test”

If your basal results are unclear, your endocrinologist may perform a dynamic stimulation test. These tests assess different parts of the hypothalamic-pituitary-adrenal or growth-hormone axis by measuring your response over several hours [2].

  • ACTH (Cosyntropin) Stim Test: You receive a synthetic version of the signal the pituitary sends to the adrenals, testing adrenal reserve. If your cortisol doesn’t rise above a specific threshold (which varies by lab assay), it confirms a deficiency [11]. Caution: A normal response can sometimes miss very recently developed central adrenal insufficiency.
  • GH Stimulation Tests: These are used if GH deficiency is suspected. Options include the Macimorelin test (an oral drink), the Glucagon test, or the Insulin Tolerance Test (ITT) [12][13]. The ITT requires close supervision because it involves briefly lowering your blood sugar [14].

Imaging and Vision: Looking at the Source

If blood work confirms a deficiency, the next step is often to look at the pituitary gland itself.

  • Sellar MRI with Contrast: A dedicated MRI of the “sella turcica” (the bony pocket where the pituitary sits) using a specific pituitary protocol is essential [15]. The use of gadolinium contrast helps doctors see small tumors or inflammation [16].
  • Visual Field Testing: If an MRI shows a tumor or lesion touching the optic chiasm (where the eye nerves cross), prompt specialist assessment is warranted, including a formal vision test [17]. This isn’t a standard eye exam; it’s a specialized map of your peripheral vision [18].

Your Diagnostic Completeness Checklist

Before finishing your workup, ensure your medical records include these data points:

  1. Timed Labs: Were cortisol and ACTH drawn specifically between 8-9 AM? [1]
  2. Paired Results: Do you have both the pituitary hormone (e.g., TSH) and the target hormone (e.g., Free T4) measured from the same draw? [2]
  3. Stimulation Peak: If you had a stim test, what was the exact “peak” number reached and what assay was used? [3]
  4. MRI Details: Does the report mention the “pituitary stalk” and “optic chiasm”? [19]
  5. Reference Ranges: Are the lab’s specific normal ranges included for every result? [3]

Common questions in this guide

Which tests are typically used to confirm hypopituitarism?
Doctors usually start with blood drawn around 8:00 to 9:00 AM to measure cortisol and other pituitary-related hormones, including free T4, TSH, IGF-1, prolactin, LH, FSH, and sex hormones. If these results are unclear, stimulation tests and a dedicated pituitary MRI may be added.
Why does the cortisol blood draw need to be done in the morning?
Cortisol and ACTH change during the day, so an early-morning sample is timed near the expected daily peak. A random result may be difficult to interpret, and a borderline morning cortisol often requires a stimulation test.
How should I understand a low or borderline morning cortisol result?
A very low morning cortisol can strongly suggest adrenal hormone deficiency, while a high result often supports a functioning adrenal axis. Intermediate values are a gray zone, and the correct cutoff depends on the laboratory assay and your clinician’s interpretation.
What happens during stimulation testing for hypopituitarism?
An ACTH stimulation test gives synthetic ACTH, also called cosyntropin, and measures whether the adrenal glands raise cortisol appropriately. Growth hormone deficiency may require a separate test, such as macimorelin, glucagon, or an insulin tolerance test, which must be performed with appropriate supervision.
Why might I need a pituitary MRI or peripheral vision test?
A dedicated pituitary MRI with contrast can show small tumors, inflammation, the pituitary stalk, and the relationship to the optic chiasm. If a lesion touches the optic chiasm, a formal visual field test may be needed to check peripheral vision.
Is it safe to stop steroid medicines before my hormone tests?
Do not stop hydrocortisone, inhaled steroids, topical steroid creams, or other prescribed glucocorticoids on your own before testing. Abruptly stopping them can cause a life-threatening adrenal crisis, so ask your endocrinologist how to manage them and disclose every medication and supplement.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on hypopituitarism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my cortisol sample taken specifically between 8:00 AM and 9:00 AM to ensure accuracy?
  2. 2.If my morning cortisol was in the 'gray zone', which dynamic stimulation test do you recommend to confirm the diagnosis?
  3. 3.Given my BMI and age, what is the specific Growth Hormone cutoff we are using for my stimulation test?
  4. 4.Does my MRI show any contact with the optic chiasm, and do I need a formal visual field test with an ophthalmologist?
  5. 5.How do these results distinguish between a problem with my pituitary gland and a problem with my hypothalamus?

References

References (19)
  1. 1

    Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.

    Fleseriu M, Hashim IA, Karavitaki N, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(11)):3888-3921 doi:10.1210/jc.2016-2118.

    PMID: 27736313
  2. 2

    Hypopituitarism.

    Higham CE, Johannsson G, Shalet SM

    Lancet (London, England) 2016; (388(10058)):2403-2415 doi:10.1016/S0140-6736(16)30053-8.

    PMID: 27041067
  3. 3

    Relationship between pituitary stalk (PS) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited.

    Wang W, Wang S, Jiang Y, et al.

    Clinical endocrinology 2015; (83(3)):369-76 doi:10.1111/cen.12788.

    PMID: 25845766
  4. 4

    Morning Serum Cortisol Level Predicts Central Adrenal Insufficiency Diagnosed by Insulin Tolerance Test.

    Gasco V, Bima C, Geranzani A, et al.

    Neuroendocrinology 2021; (111(12)):1238-1248 doi:10.1159/000514216.

    PMID: 33406519
  5. 5

    New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays.

    Javorsky BR, Raff H, Carroll TB, et al.

    Journal of the Endocrine Society 2021; (5(4)):bvab022 doi:10.1210/jendso/bvab022.

    PMID: 33768189
  6. 6

    Newborn screening for central congenital hypothyroidism: past, present and future.

    Garrelfs MR, Mooij CF, Boelen A, et al.

    European thyroid journal 2025; (14(1)).

    PMID: 39913280
  7. 7

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.

    Yuen KCJ, Biller BMK, Radovick S, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019; (25(11)):1191-1232 doi:10.4158/GL-2019-0405.

    PMID: 31760824
  8. 8

    Current concepts of the diagnosis of adult growth hormone deficiency.

    Tritos NA, Biller BMK

    Reviews in endocrine & metabolic disorders 2021; (22(1)):109-116 doi:10.1007/s11154-020-09594-1.

    PMID: 32959175
  9. 9

    Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis.

    Yuen KCJ, Johannsson G, Ho KKY, et al.

    Endocrine connections 2023; (12(7)).

    PMID: 37052176
  10. 10

    Pituitary Stalk Interruption Syndrome: A Case and Literature Review.

    Choure A, Shahla L

    AACE clinical case reports 2025; (11(1)):29-31 doi:10.1016/j.aace.2024.09.007.

    PMID: 39896953
  11. 11

    Secondary Adrenal Insufficiency and Growth Hormone Deficiency in Patients with Fibromyalgia.

    Gruber LM, Nanda S, Nippoldt T, et al.

    Journal of pain research 2021; (14()):1323-1329 doi:10.2147/JPR.S302291.

    PMID: 34040435
  12. 12

    Sensitivity and specificity of the macimorelin test for diagnosis of AGHD.

    Garcia JM, Biller BMK, Korbonits M, et al.

    Endocrine connections 2021; (10(1)):76-83.

    PMID: 33320108
  13. 13

    Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

    Hamrahian AH, Yuen KC, Gordon MB, et al.

    Pituitary 2016; (19(3)):332-41 doi:10.1007/s11102-016-0712-7.

    PMID: 26897383
  14. 14

    Diagnosis and Treatment of Hypopituitarism.

    Kim SY

    Endocrinology and metabolism (Seoul, Korea) 2015; (30(4)):443-55 doi:10.3803/EnM.2015.30.4.443.

    PMID: 26790380
  15. 15

    Neuroendocrine disorders: pituitary imaging.

    Faje A, Tritos NA, Swearingen B, Klibanski A

    Handbook of clinical neurology 2016; (136()):873-85.

    PMID: 27430447
  16. 16

    Pituitary Metastasis Presenting With Central Diabetes Insipidus and Panhypopituitarism.

    Parthasarathy S, Lee DH, Levitt AH, Manavalan A

    AACE clinical case reports 2022; (8(1)):15-18 doi:10.1016/j.aace.2021.06.006.

    PMID: 35097195
  17. 17

    Diagnosis and Management of Pituitary Adenomas: A Review.

    Tritos NA, Miller KK

    JAMA 2023; (329(16)):1386-1398 doi:10.1001/jama.2023.5444.

    PMID: 37097352
  18. 18

    Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

    Ntali G, Wass JA

    Pituitary 2018; (21(2)):111-118 doi:10.1007/s11102-018-0869-3.

    PMID: 29368293
  19. 19

    Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects.

    Mercado M, Melgar V, Salame L, Cuenca D

    Endocrinologia, diabetes y nutricion 2017; (64(7)):384-395 doi:10.1016/j.endinu.2017.05.009.

    PMID: 28745610

This page is for informational purposes only and does not constitute medical advice. It explains hypopituitarism testing; do not stop steroid medicines before testing unless your endocrinologist specifically instructs you.